BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15278297)

  • 1. Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia.
    Gomis F; Sanz J; Sempere A; Plumé G; Senent ML; Pérez ML; Cervera J; Moscardó F; Bolufer P; Barragán E; Martín G; Sanz MA
    Ann Hematol; 2004 Nov; 83(11):687-90. PubMed ID: 15278297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).
    Falini B; Flenghi L; Fagioli M; Lo Coco F; Cordone I; Diverio D; Pasqualucci L; Biondi A; Riganelli D; Orleth A; Liso A; Martelli MF; Pelicci PG; Pileri S
    Blood; 1997 Nov; 90(10):4046-53. PubMed ID: 9354674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3.
    Villamor N; Costa D; Aymerich M; Esteve J; Carrió A; Rozman M; Aguilar JL; Falini B; Montserrat E; Campo E; Colomer D
    Am J Clin Pathol; 2000 Nov; 114(5):786-92. PubMed ID: 11068554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostaining for rapid diagnosis of acute promyelocytic leukemia with the tetramethylrhodamine-5-isothiocyanate-conjugated anti-promyelocytic leukemia monoclonal antibody PG-M3.
    Alayed KM; Medeiros LJ; Phan D; Ojiaku C; Patel J; Yap JP; McCord Y; Woods JS; Konoplev S; Bueso-Ramos CE; Reyes SR
    Arch Pathol Lab Med; 2013 Nov; 137(11):1669-73. PubMed ID: 24168508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunofluorescent assay for acute promyelocytic leukemia cells.
    Samoszuk MK; Tynan W; Sallash G; Nasr S; Monczak Y; Miller WH
    Am J Clin Pathol; 1998 Feb; 109(2):205-10. PubMed ID: 9583893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
    Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
    Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients.
    Dimov ND; Medeiros LJ; Kantarjian HM; Cortes JE; Chang KS; Bueso-Ramos CE; Ravandi F
    Cancer; 2010 Jan; 116(2):369-76. PubMed ID: 19950129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia.
    Flenghi L; Fagioli M; Tomassoni L; Pileri S; Gambacorta M; Pacini R; Grignani F; Casini T; Ferrucci PF; Martelli MF
    Blood; 1995 Apr; 85(7):1871-80. PubMed ID: 7535592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
    Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
    Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improved RT-PCR for detection of PML/RARalpha fusion gene in rapid diagnosis of acute promyelocytic leukemia].
    Liu ZL; Luo JM; Wang FX; Zhang XJ; Du XY; Yao L; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):587-90. PubMed ID: 14706140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-alpha protein.
    Dyck JA; Warrell RP; Evans RM; Miller WH
    Blood; 1995 Aug; 86(3):862-7. PubMed ID: 7620182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid diagnosis of acute promyelocytic leukemia (PML): applicability of flow cytometry and PML protein immunofluorescence.
    Cullen MJ; Richards SJ; O'Connor SJ; Dickinson H; Sharpe C; Swirsky DM; Owen R
    Cancer Genet Cytogenet; 2004 Jan; 148(2):176-7. PubMed ID: 14734236
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of PG-M3 antibody in the diagnosis of acute promyelocytic leukaemia.
    Gupta SK; Sazawal S; Mahapatra M; Saxena R
    Eur J Clin Invest; 2010 Oct; 40(10):960-2. PubMed ID: 20701624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change of PML/PML-RARalpha protein during treatment with tetraarsenic tetrasulfide (As4S4) in patients with acute promyelocytic leukemia].
    Wang JZ; Liu YR; Qin YZ; Jiang H; Wang FR; Bao L; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):464-8. PubMed ID: 14575537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid diagnostic approach to PML-RARalpha-positive acute promyelocytic leukemia.
    Schoch C; Schnittger S; Kern W; Lengfelder E; Löffler H; Hiddemann W; Haferlach T
    Hematol J; 2002; 3(5):259-63. PubMed ID: 12391544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
    Grimwade D; Howe K; Langabeer S; Burnett A; Goldstone A; Solomon E
    Leukemia; 1996 Jan; 10(1):61-6. PubMed ID: 8558940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.
    Sucić M; Zadro R; Burazer B; Labar B; Nemet D; Mrsić M; Aurer I; Mrsić S; Hitrec V; Boban D; Marković-Glamocak M; Batinić D; Uzarević B; Stavljenić-Rukavina A
    J Hematother Stem Cell Res; 2002 Dec; 11(6):941-50. PubMed ID: 12590709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.